Results for tag: "Lichen Planus Drug"

Lichen planus is a chronic inflammatory skin condition that affects the skin, nails, and mucous membranes. It is characterized by an itchy, scaly rash that can cause pain and discomfort. Treatment for lichen planus typically involves topical corticosteroids, topical calcineurin inhibitors, and oral medications. The lichen planus drug market is a subset of the dermatological drugs market. It is composed of a variety of medications used to treat lichen planus, including topical corticosteroids, topical calcineurin inhibitors, and oral medications. These medications are used to reduce inflammation, itching, and pain associated with the condition. Some companies in the lichen planus drug market include GlaxoSmithKline, Pfizer, Merck, and Novartis. These companies produce a variety of medications used to treat lichen planus, including topical corticosteroids, topical calcineurin inhibitors, and oral medications. Show Less Read more